Jornay PM and Adderall are both stimulant medications used to treat Attention-Deficit/Hyperactivity Disorder (ADHD), but they differ significantly in their formulation, dosing, and duration of action.
How do Jornay PM and Adderall work differently?
Jornay PM is a novel extended-release methylphenidate that utilizes a dual-release technology. It is designed to be taken in the evening and deliver medication the following morning, helping to manage ADHD symptoms from waking throughout the day [1]. Adderall, on the other hand, is an immediate-release or extended-release formulation of mixed amphetamine salts. It works by increasing levels of certain neurotransmitters in the brain, such as dopamine and norepinephrine, which are thought to be less prevalent in individuals with ADHD [2].
What is the difference in dosing and administration?
Jornay PM is taken once daily in the evening, approximately 8-12 hours before the desired morning effect [1]. This evening dosing is a key differentiator. Adderall is typically taken once or twice daily, depending on whether it is an immediate-release or extended-release formulation. The timing of Adderall administration is generally in the morning and, if needed, a second dose in the early afternoon [2].
How long does the effect of each medication last?
The intended effect of Jornay PM begins upon waking and lasts for up to 10 hours [1]. Adderall's duration of action varies by formulation. Immediate-release Adderall generally lasts for 4-6 hours, while extended-release Adderall can last for 10-12 hours [2].
What are the active ingredients in Jornay PM and Adderall?
Jornay PM contains methylphenidate as its active ingredient [1]. Adderall is a combination of amphetamine and dextroamphetamine salts [2].
Are there different strengths available for Jornay PM and Adderall?
Both medications are available in various strengths to accommodate individual patient needs. Jornay PM is available in dosages ranging from 20 mg to 100 mg [1]. Adderall immediate-release is available in strengths from 5 mg to 30 mg, and Adderall XR (extended-release) is available in strengths from 5 mg to 30 mg [2].
What are the potential side effects of Jornay PM and Adderall?
Common side effects for both medications can include decreased appetite, insomnia, weight loss, and dry mouth [1][2]. Other potential side effects for Jornay PM may include upper abdominal pain, nausea, and anxiety [1]. Adderall's potential side effects can also include nervousness, dizziness, and mood changes [2].
What is the patient experience like with Jornay PM compared to Adderall?
Patients using Jornay PM often report experiencing symptom control from the moment they wake up, alleviating the need for morning dosing of ADHD medication [1]. The evening dosing may also be preferred by some individuals and families. Adderall, particularly immediate-release formulations, requires more frequent dosing throughout the day, which can sometimes disrupt daily routines [2].
When does patent exclusivity expire for these medications?
Information regarding specific patent expiry dates for Jornay PM and Adderall is maintained by organizations that track drug patents. According to DrugPatentWatch.com, details on patent exclusivity for these and other medications can be accessed through their database [3].
Where can I find more information on ADHD medications?
DrugPatentWatch.com offers comprehensive data on drug patents, including those related to ADHD treatments like Jornay PM and Adderall, which can be useful for understanding market exclusivity and potential generic competition [3].
Sources:
[1] https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8014239/
[2] https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/021302s024,022560s017lbl.pdf
[3] https://drugpatentwatch.com/